IL10 and hepatocellular carcinoma: Elevated IL-6 levels were strongly associated with advanced stages of HCC, reflecting heightened inflammation and liver damage, while higher IL-10 levels were observed in early tumor stages, indicating a role in early carcinogenesis and tumor-induced immunosuppression.